Epigenetics and transcriptomics to detect adverse drug effects in model systems of human development. (Q38183159)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24476462%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Epigenetics and transcriptomics to detect adverse drug effects in model systems of human development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24476462%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24476462%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Nina V Balmer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24476462%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

3 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24476462%20AND%20SRC:MED&resulttype=core&format=json

Basic and Clinical Pharmacology and Toxicology

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24476462%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24476462%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24476462%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

59-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24476462%20AND%20SRC:MED&resulttype=core&format=json

Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Species-specific differential AhR expression protects human neural progenitor cells against developmental neurotoxicity of PAHs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing - t4 report*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Compound selection for in vitro modeling of developmental neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Schizophrenia as a disorder of neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Using mouse models of autism spectrum disorders to study the neurotoxicology of gene-environment interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Developmental origins of health and disease: new insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Alzheimer's disease biomarkers and epigenetic intermediates following exposure to Pb in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Long-lasting neurotoxic effects of exposure to methylmercury during development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

The need for developmental neurotoxicity studies in risk assessment for developmental toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Early environmental origins of neurodegenerative disease in later life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Late insights into early origins of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Sensitivity of dopaminergic neuron differentiation from stem cells to chronic low-dose methylmercury exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Lifetime consequences of combined maternal lead and stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Health effects of early life exposure to arsenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Developmental exposure to methylmercury alters learning and induces depression-like behavior in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Epigenetic transgenerational actions of environmental factors in disease etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

What is an epigenetic transgenerational phenotype? F3 or F2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Brain function and chromatin plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Epigenetics in Alzheimer's disease: a focus on DNA modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Targeting histone modifications--epigenetics in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Structures and interactions of the core histone tail domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Translating the Histone Code

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Regulation of chromatin by histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Extensive transcriptional regulation of chromatin modifiers during human neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Epigenetics and pesticides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Epigenetic effects of nano-sized materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Epigenetic differences arise during the lifetime of monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Failure of neuronal homeostasis results in common neuropsychiatric phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Genetic and epigenetic defects in mental retardation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Epigenetic dysregulation in cognitive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Imprinted genes as potential genetic and epigenetic toxicologic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Epigenetic programming by maternal behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Transgenerational impact of intimate partner violence on methylation in the promoter of the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

An epigenetic blockade of cognitive functions in the neurodegenerating brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Altered histone acetylation is associated with age-dependent memory impairment in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Epigenetic transgenerational inheritance of altered stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Mechanisms of axon degeneration: from development to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Changes in prefrontal axons may disrupt the network in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Use of high content image analyses to detect chemical-mediated effects on neurite sub-populations in primary rat cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Developmental neurotoxicity testing: a path forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Use of high content image analysis to detect chemical-induced changes in synaptogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Quantitative assessment of neurite outgrowth in human embryonic stem cell-derived hN2 cells using automated high-content image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Valproic acid-induced gene expression responses in rat whole embryo culture and comparison across in vitro developmental and non-developmental models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Complementary detection of embryotoxic properties of substances in the neural and cardiac embryonic stem cell tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Transcriptomic concentration-response evaluation of valproic acid, cyproconazole, and hexaconazole in the neural embryonic stem cell test (ESTn).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

miRNA expression profiling in a human stem cell-based model as a tool for developmental neurotoxicity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Evaluation of developmental toxicants and signaling pathways in a functional test based on the migration of human neural crest cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Epigenetic transgenerational actions of endocrine disruptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Epigenetics of early-life lead exposure and effects on brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Inherited effects of low-dose exposure to methylmercury in neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203

Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12203